Posted On: Thursday, November 6th, 2014
New and Noteworthy Interactions with transplant drugs added to simeprevir product monograph The U.S. Food and Drug Administration (FDA) recently approved revisions to the product label information for the direct-acting anti-viral medication simeprevir, known by the brand name Galexos in Canada. The revisions highlighted drug interactions with cyclosporine and tacrolimus, which are used to prevent… Read more »
Posted On: Saturday, October 11th, 2014
Posted On: Saturday, October 11th, 2014
New and Noteworthy CATIE-News: A hepatitis C outbreak among HIV-negative gay men in London, England Some HIV-negative gay men may be at risk for getting hepatitis C. Researchers from London, England found 44 cases of acute Hep C infection in HIV-negative gay men between 2010 and 2014. Among HIV-positive gay men, hepatitis C has been… Read more »
Posted On: Friday, October 3rd, 2014
Take this survey It is 36, mostly multiple choice, questions that are divided into 5 sections. Sections that don’t pertain to you can be easily skipped. The survey’s 5 sections ask about: The impact of hep C on your life (8 questions) Your experience with current hep C treatments (9 questions) The impact on caregivers… Read more »
Posted On: Friday, September 26th, 2014
Posted On: Wednesday, September 17th, 2014
New and Noteworthy Expanded harm reduction services decreased new Hep C infections in Scotland Implementing comprehensive harm reduction services averted an estimated 1400 new Hep C infections in Scotland, reported researchers in PLOS ONE. In 2008, the Scottish government expanded access to sterile injecting equipment, including needles, syringes, cookers, filters and water, and improved access… Read more »
Posted On: Wednesday, September 10th, 2014
Posted On: Thursday, August 21st, 2014
New and Noteworthy High risk of Hep C among Vancouver street youth From 2005 to 2011, 940 youth were recruited into the At-Risk Youth Study. All youth completed an initial Hep C test and just over 10% were found to be Hep C positive. Of the 512 Hep C-negative youth who were retested every six… Read more »
Posted On: Wednesday, August 6th, 2014
New and Noteworthy Health Canada approves a stand-alone ribavirin pill Health Canada has approved a stand-alone ribavirin pill known by the brand name Ibavyr. Traditionally, ribavirin has been available for Hep C treatment in combination with peg-interferon. A stand-alone ribavirin pill is necessary for some treatments with sofosbuvir (Sovaldi) as well as other interferon-free combinations… Read more »
Posted On: Thursday, July 17th, 2014
Everyone welcome! GREAT GUEST SPEAKERS Medical experts & “positive” people 1-hour exciting new Canadian FILM ABOUT HEPATITIS C HEPATITIS B and C INFORMATION BOOTHS from local organizations World Hepatitis Day Vancouver 2014 Planning Committee includes representatives from: S.U.C.C.E.S.S., the BC Centre for Excellence in HIV/AIDS, HepCBC Hepatitis C Education and Prevention Society, the BC… Read more »
Posted On: Wednesday, July 9th, 2014
Sage is a community-driven space for organizations and other HIV and hepatitis C service providers in Canada to share and archive their digital information resources and connect with peers in the field. Examples of recently added resources: Opposites Attract: A Guide for Magnetic Relationships Moving Knowledge into Action: An evaluation of the impact of CATIE’s… Read more »
Posted On: Wednesday, June 18th, 2014
The Vancouver World Hepatitis Day (WHD) 2014 Planning Committee would like to invite you to participate in the WHD 2014 event at the Vancouver Art Gallery as an Exhibitor by renting an information booth / table to display and distribute Hepatitis-related information and resources. There is no registration fee however, each organization will be responsible for the cost… Read more »
